ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,095Medicare Part D Prescriptions Filled, Including Refills

Rank: 164 out of 617

$418K Total Retail Price of All Prescriptions

Rank: 144 out of 617

460 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
33% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nebraska
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 460 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

13% of this provider’s 460 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

2% of this provider’s 6,957 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$52 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

18 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nebraska
OMEPRAZOLE 327 289 1 3
HYDROCODONE-ACETAMINOPHEN 291 237 S3 2 8
LEVOTHYROXINE SODIUM 280 250 3 1
SIMVASTATIN 227 193 4 2
AMLODIPINE BESYLATE 222 197 5 6
LISINOPRIL 217 202 6 5
WARFARIN SODIUM 189 174 7 7
METOPROLOL SUCCINATE 187 184 8 12
FUROSEMIDE 180 160 9 4
SERTRALINE HCL 152 133 10 20
TAMSULOSIN HCL 144 143 11 26
HYDROCHLOROTHIAZIDE 142 142 12 13
POTASSIUM CHLORIDE 141 139 13 10
LOSARTAN POTASSIUM 127 127 14 22
METOPROLOL TARTRATE 125 114 15 11
ADVAIR DISKUS 122 122 16 38
TRAMADOL HCL 108 106 17 15
DIGOXIN 108 103 17 48
PREDNISONE 107 88 19 31
ATORVASTATIN CALCIUM 104 104 20 14
ZOLPIDEM TARTRATE 101 100 21 23
METFORMIN HCL 99 70 22 9
CARVEDILOL 99 95 22 19
ENALAPRIL MALEATE 94 69 24 34
ALENDRONATE SODIUM 92 91 25 25
AMITRIPTYLINE HCL 87 67 R 26 56
DIOVAN 83 83 27 41
TRIAMTERENE-HCTZ 80 80 28 47
CITALOPRAM HBR 79 51 29 18
PRAVASTATIN SODIUM 72 72 30 21
PROAIR HFA 65 55 31 75
ETODOLAC 62 56 32 195
DICLOFENAC SODIUM 62 54 32 98
OXYCODONE-ACETAMINOPHEN 54 42 S2 34 93
PAROXETINE HCL 54 44 34 62
LABETALOL HCL 53 39 36 224
LANTUS 50 50 37 39
METHOTREXATE 50 37 37 250
TRIAMCINOLONE ACETONIDE 50 43 37 102
NAPROXEN 50 44 37 101
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 26, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.